News Releases

2012

18 January 2012 APR Applied Pharma Research s.a. (“APR”), Labtec GmbH (“Labtec”) and Norgine BV (“Norgine”) announce the signature of an exclusive licensing agreement under which Norgine will market and distribute Setofilm™ Ondansetron Oral Dispersible Film view

15 January 2012 Clinical Trial Results : Evaluation of Acceptability, Tolerability, Safety and Efficacy of MOVIPREP® Orange (NRL0706-01/2009) view